Select Page

Cherry Hill: Daughter’s opioid death caused by ‘corporate greed’

As Seen In:

ABC Nightline logo, featured in the context of showcasing Richard J. Hollawell's successful personal injury case results and media recognition.
New York Times logo featured in the context of Richard J. Hollawell's personal injury law firm showcasing case results and significant settlements.
Logo of Richard J. Hollawell, personal injury attorney, representing successful case results and legal expertise in Pennsylvania, New Jersey, and New York.
The Wall Street Journal logo, representing media coverage of Richard J. Hollawell's successful personal injury law practice.
Image depicting case results and legal achievements of Richard J. Hollawell, showcasing significant settlements in personal injury law, including a $9 million settlement related to fentanyl distribution violations.

GET A FREE CONSULTATION

Sen. McCaskill Hearing Exposes Insys’ Opioid Marketing Abuses

RECENT RESULTS

$4.5M wrongful death settlement due to opioid overprescription, highlighting legal advocacy for personal injury victims in Camden County.
Motor vehicle accident settlement of $1.7M due to drunk driver negligence, highlighting successful personal injury case results.
$750K settlement for personal injury case involving a tractor trailer accident, highlighting successful legal representation by Camden County personal injury lawyers.

U.S. Sen. Claire McCaskill (D., Mo.) took aim during a hearing Tuesday at marketing practices by the pharmaceutical industry generally and the behavior of one company in particular: Insys Therapeutics Inc., which made the powerful opioid believed to have played a role in the death of 32-year-old Sarah Fuller in Camden County last year.

Her mother, Deborah, described listening to an audio recording in which a drug company representative falsely said she was from Sarah’s doctor’s office and misled a pharmacy benefits manager into believing that Sarah had breakthrough cancer pain. That’s the only condition that Insys’ fast-acting fentanyl brand, Subsys, was approved to treat.

Read the full story on Philly.com

    Ready for a no-cost consultation?

    Speak directly to Richard Hollawell today - there is never a fee until we win your case.

    You have Successfully Subscribed!